NBIX

NEUROCRINE BIOSCIENCES INC

Name: NEUROCRINE BIOSCIENCES INC insider trading (SEC Form 4) history
Creator: U.S. Securities and Exchange Commission

SEC CIK 914475

$156.42 +10.8% · 90 days

90-day buys

0 open-market

90-day sells

$17.51M

17 open-market

Net insider flow

−$17.51M

Net selling

Filings shown

115

Most recent

At a glance

Over the last 90 days, insiders at NBIX have sold a net $17.51M of stock (0 open-market buys vs 17 sells).

Largest recent trade: Onyia Jude sold $7.8M of NBIX, trimming their stake 77%.

Most active filer: Abernethy Matt, with 33 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for NBIX, newest first

View on SEC EDGAR ↗

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Aug 23, 2023 ΔOwn −7.3%

Abernethy Matt sold $229K of NBIX, trimming their stake 7%.

−$229K

2,132 sh @ $107

NBIX

NEUROCRINE BIOSCIENCES INC

Sell RASTETTER WILLIAM H · Director · Open-market sale · filed May 3, 2023 ΔOwn −9.1%

Rastetter William H sold $436.1K of NBIX, trimming their stake 9%.

−$436.1K

4,300 sh @ $101

NBIX

NEUROCRINE BIOSCIENCES INC

Sell RASTETTER WILLIAM H · Director · Open-market sale · filed Apr 21, 2023 ΔOwn −13%

Rastetter William H sold $633.8K of NBIX, trimming their stake 13%.

−$633.8K

6,034 sh @ $105

NBIX

NEUROCRINE BIOSCIENCES INC

Sell RASTETTER WILLIAM H · Director · Open-market sale · filed Apr 21, 2023 ΔOwn −2.5%

Rastetter William H sold $94.8K of NBIX, trimming their stake 3%.

−$94.8K

903 sh @ $105

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 8, 2023 ΔOwn −3.7%

Abernethy Matt sold $102.1K of NBIX, trimming their stake 4%.

−$102.1K

980 sh @ $104

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 8, 2023 ΔOwn −7.7%

Abernethy Matt sold $207.7K of NBIX, trimming their stake 8%.

−$207.7K

2,030 sh @ $102

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 8, 2023 ΔOwn −26%

Abernethy Matt sold $1.31M of NBIX, trimming their stake 26%.

−$1.31M

12,807 sh @ $102

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 8, 2023 ΔOwn −32%

Abernethy Matt sold $1.18M of NBIX, trimming their stake 32%.

−$1.18M

11,491 sh @ $102

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 8, 2023 ΔOwn −5.4%

Abernethy Matt sold $135.3K of NBIX, trimming their stake 5%.

−$135.3K

1,280 sh @ $106

NBIX

NEUROCRINE BIOSCIENCES INC

Sell RASTETTER WILLIAM H · Director · Open-market sale · filed Apr 5, 2022 ΔOwn −24%

Rastetter William H sold $1.02M of NBIX, trimming their stake 24%.

−$1.02M

10,728 sh @ $95

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 9, 2022 ΔOwn −4.6%

Abernethy Matt sold $78.1K of NBIX, trimming their stake 5%.

−$78.1K

980 sh @ $80

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 9, 2022 ΔOwn −10%

Abernethy Matt sold $164K of NBIX, trimming their stake 10%.

−$164K

2,030 sh @ $81

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 9, 2022 ΔOwn −6.2%

Abernethy Matt sold $103.4K of NBIX, trimming their stake 6%.

−$103.4K

1,280 sh @ $81

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Dec 3, 2021 ΔOwn −9.1%

Abernethy Matt sold $135.9K of NBIX, trimming their stake 9%.

−$135.9K

1,645 sh @ $83

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −6.3%

Abernethy Matt sold $102.8K of NBIX, trimming their stake 6%.

−$102.8K

880 sh @ $117

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −12%

Abernethy Matt sold $237.1K of NBIX, trimming their stake 12%.

−$237.1K

2,030 sh @ $117

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Dec 2, 2020 ΔOwn −13%

Abernethy Matt sold $155.7K of NBIX, trimming their stake 13%.

−$155.7K

1,645 sh @ $95

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Nov 16, 2020 ΔOwn −18%

Abernethy Matt sold $204.8K of NBIX, trimming their stake 18%.

−$204.8K

2,257 sh @ $91

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Aug 7, 2020 ΔOwn −22%

Abernethy Matt sold $268.4K of NBIX, trimming their stake 22%.

−$268.4K

2,257 sh @ $119

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed May 11, 2020 ΔOwn −72%

Abernethy Matt sold $1.65M of NBIX, trimming their stake 72%.

−$1.65M

15,000 sh @ $110

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Apr 30, 2020 ΔOwn −23%

Abernethy Matt sold $178.4K of NBIX, trimming their stake 23%.

−$178.4K

1,741 sh @ $102

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Apr 28, 2020 ΔOwn −20%

Abernethy Matt sold $192.5K of NBIX, trimming their stake 20%.

−$192.5K

1,934 sh @ $100

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Feb 11, 2020 ΔOwn −26%

Abernethy Matt sold $209.8K of NBIX, trimming their stake 26%.

−$209.8K

2,030 sh @ $103

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Dec 4, 2019 ΔOwn −30%

Abernethy Matt sold $191.4K of NBIX, trimming their stake 30%.

−$191.4K

1,645 sh @ $116

NBIX

NEUROCRINE BIOSCIENCES INC

Sell ABERNETHY MATT · Chief Financial Officer · Open-market sale · filed Dec 6, 2018 ΔOwn −38%

Abernethy Matt sold $106K of NBIX, trimming their stake 38%.

−$106K

1,178 sh @ $90

About NBIX insider activity

This page tracks every recent Form 4 filed for NEUROCRINE BIOSCIENCES INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is NBIX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for NEUROCRINE BIOSCIENCES INC usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.